Among ADMs, semaglutide continues to be the most prescribed medication (1.34% of all prescriptions) , although prescription rates decreased (-3.92%)
This week, the FDA officially removed Novo Nordisks popular weight-loss and diabetes medications, Wegovy and Ozempic , from its drug shortage list, indicating that supply now meets or exceeds U.S
To view a copy of this licence, visit About this article Cite this article Zheng, Z., Zong, Y., Ma, Y
Semaglutide is a synthetic 31-amino-acid analogue of human GLP-1 (glucagon-like peptide-1), developed by Novo Nordisk and first authorized by Health Canada in 2018 under the brand name Ozempic
Currently, the drugs are very expensive and are not yet covered for weight loss by some insurance companies
Though Rogers reports no adverse effects from taking semaglutide, she also acknowledges that because these medications are so new, its still uncertain whether there could be long-term adverse effects waiting for her down the road: I dont know what will happen in 10 years will my ears fall off or will I grow a third eyebrow? But shes willing to take that chance in exchange for feeling better and running well now
